Professor, Chief Physician at Huazhong University of Science and Technology Tongji Medical College Tongji Hospital, China
Professor Minghuan Wang is a distinguished researcher and clinician serving as Chief Physician and Professor in the Department of Neurology at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Recognized as a Youth Changjiang Scholar and recipient of the Hubei Science Fund for Distinguished Young Scholars, he is acknowledged for his exceptional contributions to neuroscience and cerebrovascular research. He leads three projects under the National Natural Science Foundation and has published over 30 influential papers in top-tier journals including Lancet Respiratory Medicine, Lancet Digital Health, and Science Translational Medicine. His editorial role with Fundamental Research and memberships in national scientific societies underscore his leadership and commitment to advancing neurological science. While expanding international collaboration and translational impact could enhance his global influence, his academic excellence, research productivity, and clinical insight make him a highly deserving candidate for the Best Researcher Award.
Professional Profile
Education🎓
Professor Minghuan Wang has received comprehensive and rigorous medical and academic training that laid the foundation for his career in clinical neurology and neuroscience research. He pursued his medical education and advanced specialization at prestigious institutions affiliated with Huazhong University of Science and Technology, one of China’s top medical universities. Through his academic journey, he gained deep expertise in neurology, cerebrovascular diseases, and translational medicine, which are reflected in both his clinical practice and scientific output. His educational background is marked by excellence in both theoretical knowledge and practical application, positioning him to contribute significantly to clinical research and innovation. In addition to his formal medical education, Prof. Wang has continually engaged in advanced academic programs and national training initiatives, such as the China Stroke Future Leaders Program, which further enhanced his leadership, research methodology, and collaborative competencies. His educational credentials underscore his readiness to lead cutting-edge research and mentor the next generation of scientists.
Professional Experience📝
Professor Minghuan Wang has accumulated extensive professional experience as both a clinician and a researcher in the field of neurology. He currently serves as a Professor and Chief Physician at the Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, a leading medical institution in China. With a strong clinical background, he specializes in the diagnosis, treatment, and research of cerebrovascular and neurological disorders. His professional roles extend beyond clinical care, as he also leads multiple national research projects, including three funded by the National Natural Science Foundation of China. He holds several leadership positions in prominent medical and scientific organizations, including the China Stroke Society and the Chinese Society for Neuroscience. His involvement in national committees, editorial boards, and scientific review panels reflects his expertise and influence in shaping the direction of neurological research in China. Prof. Wang’s professional career exemplifies excellence, leadership, and impact.
Research Interest🔎
Professor Minghuan Wang’s research interests lie primarily in the fields of neurology, cerebrovascular diseases, and translational neuroscience. He focuses on the mechanisms, diagnosis, and treatment of stroke and other high-risk cerebrovascular conditions, aiming to bridge the gap between clinical practice and laboratory science. His work integrates clinical neurology with cutting-edge biomedical research, particularly in understanding the role of glial cells, neuroinflammation, and neural repair processes. Prof. Wang is also deeply involved in developing novel biomarkers and digital health technologies to improve early diagnosis and individualized treatment strategies for neurological disorders. His participation in the China Stroke Future Leaders Program reflects his dedication to advancing stroke prevention and management at a national level. Through leading multiple national research grants and publishing in top-tier journals, he contributes significantly to the scientific community’s understanding of neurological diseases and fosters innovative approaches to improve patient care and health outcomes in neurovascular medicine.
Award and Honor🏆
Professor Minghuan Wang has received numerous prestigious awards and honors in recognition of his outstanding contributions to neurology and medical research. He is a Youth Changjiang Scholar, one of the most distinguished academic titles awarded by the Ministry of Education in China, acknowledging his exceptional research leadership and innovation. He was also honored with the Hubei Science Fund for Distinguished Young Scholars, reflecting his impact on regional scientific advancement. Prof. Wang has been recognized as a Top Talent of Hubei Province and a Key Medical Talent in Wuhan, affirming his pivotal role in clinical excellence and healthcare development. His selection for the China Stroke Future Leaders Program by the China Stroke Society further illustrates his national influence in stroke research and prevention. These accolades, along with his active participation in editorial boards and scientific committees, highlight his commitment to scientific excellence and his growing reputation as a leader in neuroscience research.
Research Skill🔬
Professor Minghuan Wang possesses a robust set of research skills that reflect his interdisciplinary expertise and scientific rigor. His strengths lie in clinical research design, data analysis, translational neuroscience, and the integration of advanced biomedical techniques to investigate cerebrovascular and neurological disorders. He excels in conducting high-impact studies, as evidenced by his publications in leading journals such as The Lancet series and Science Translational Medicine. Prof. Wang demonstrates advanced proficiency in identifying novel biomarkers, applying digital health tools, and utilizing cellular and molecular biology methods to explore mechanisms of disease. His leadership in securing and managing multiple National Natural Science Foundation projects highlights his strong grant-writing and project management abilities. Furthermore, his collaborative skills and involvement in national medical committees underscore his capacity to work across disciplines and lead multi-institutional research initiatives. These capabilities, combined with his clinical insight, make him a highly effective and innovative researcher in the field of neurology.
Conclusion💡
Prof. Minghuan Wang is highly suitable for the Best Researcher Award. His robust academic foundation, leadership in neurology, and impactful publication record position him as a front-runner in the field. His work contributes significantly to neuroscience and stroke research, and he exemplifies the qualities of a transformative researcher. With minor expansion in international outreach and translational application, his profile aligns excellently with the award’s core criteria.
Publications Top Noted✍️
-
Xu, S.; Luo, X.; Wang, M.; et al.
(2025)
“Genome-wide and phenome-wide studies provided novel insight into brain glymphatic system function and its clinical associations.”
Journal: Science Advances
DOI: 10.1126/sciadv.adr4606
-
Xie, Y.; Liu, S.; Wang, X.; Huang, H.; Wang, M.; et al.
(2024)
“Lipids, Apolipoproteins, Lipid‐Lowering Drugs, and the Risk of Cerebral Small Vessel Disease: A Mendelian Randomization Study.”
Journal: Journal of the American Heart Association
DOI: 10.1161/JAHA.123.032409
-
Wang, M.; Ran, L.; Liu, B.; Wei, W.; Zhu, J.; et al.
(2023)
“Disturbed meningeal lymphatic function associated with malignancy and progression in patients with intracranial malignant tumors.”
Journal: Med
DOI: 10.1016/j.medj.2023.10.001
-
Chen, P.; Li, Y.; Liu, R.; Xie, Y.; Jin, Y.; Wang, M.; et al.
(2023)
“Non–small cell lung cancer-derived exosomes promote proliferation, phagocytosis, and secretion of microglia via exosomal microRNA in the metastatic microenvironment.”
Journal: Translational Oncology
DOI: 10.1016/j.tranon.2022.101594
-
Li, J.; Hao, J-H.; Yao, D.; Li, R.; Li, X-F.; Yu, Z-Y.; Luo, X.; Liu, X-H.; Wang, M-H.; Wang, W.
(2020)
“Caspase‐1 inhibition prevents neuronal death by targeting the canonical inflammasome pathway of pyroptosis in a murine model of cerebral ischemia.”
Journal: CNS Neuroscience & Therapeutics
DOI: 10.1111/cns.13384
-
Fang, Y.; Qin, T.; Liu, W.; Ran, L.; Yang, Y.; Huang, H.; Pan, D.; Wang, M.
(2020)
“Cerebral Small‐Vessel Disease and Risk of Incidence of Depression: A Meta‐Analysis of Longitudinal Cohort Studies.”
Journal: Journal of the American Heart Association
DOI: 10.1161/JAHA.120.016512
-
Wang, M.
(2024)
Supplementary Tables S11–S17
Datasets (Figshare):
